Published in PLoS One on April 17, 2015
Dopamine D2 Receptor-Mediated Regulation of Pancreatic β Cell Mass. Stem Cell Reports (2016) 0.76
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes (2005) 5.54
Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes (2000) 4.16
On the origin of the beta cell. Genes Dev (2008) 3.34
Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem (1995) 2.43
Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem (1999) 2.38
Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol (1999) 2.37
Life and death of the pancreatic beta cells. Trends Endocrinol Metab (2000) 2.24
The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity (1999) 1.98
Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem (2005) 1.39
The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions. Mol Cell Endocrinol (2012) 1.32
Evolution and cell biology of dopamine receptors in vertebrates. Biol Cell (2003) 1.28
Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care (2008) 1.24
Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol (2008) 1.13
Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab (2009) 1.10
Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro. IUBMB Life (2006) 1.07
Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance. Endocrinology (2010) 1.03
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. Biochem Pharmacol (2010) 1.00
Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia (1977) 0.95
Prolonged culture in low glucose induces apoptosis of rat pancreatic beta-cells through induction of c-myc. Biochem Biophys Res Commun (2003) 0.95
Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice. Eur J Endocrinol (2003) 0.94
Intrinsic-mediated caspase activation is essential for cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A (2013) 0.94
Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations. Mol Endocrinol (2012) 0.93
Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet. Mol Endocrinol (2013) 0.92
VMAT2 identified as a regulator of late-stage β-cell differentiation. Nat Chem Biol (2013) 0.92
Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology (2001) 0.91
Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels. Br J Pharmacol (2010) 0.90
Dopamine induces apoptosis in young, but not in neonatal, neurons via Ca2+-dependent signal. Am J Physiol Cell Physiol (2007) 0.90
Tyrosine hydroxylase activity in the endocrine pancreas: changes induced by short-term dietary manipulation. BMC Endocr Disord (2003) 0.90
New insights into the endocrine and metabolic roles of dopamine D2 receptors gained from the Drd2 mouse. Neuroendocrinology (2010) 0.89
Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro. Mol Endocrinol (2012) 0.89
Executioners of apoptosis in pancreatic {beta}-cells: not just for cell death. Am J Physiol Endocrinol Metab (2009) 0.88
Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. PLoS One (2011) 0.87
Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster. Diabetologia (1980) 0.86
Inhibition of protein synthesis sequentially impairs distinct steps of stimulus-secretion coupling in pancreatic beta cells. Endocrinology (2001) 0.86
Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease. Eur Neurol (1976) 0.86
Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC Endocr Disord (2001) 0.83
Effects of L-dopa-induced dopamine accumulation on 45Ca2+ efflux and insulin secretion in isolated rat islets. Pharmacology (1985) 0.81
Distinctive expression and cellular distribution of dopamine receptors in the pancreatic islets of rats. Cell Tissue Res (2014) 0.81
Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Metabolism (2001) 0.81
Adrenaline inhibition of insulin release: role of cyclic AMP. Mol Cell Endocrinol (1991) 0.80
Effect of endogenous catecholamines on apoptosis of Con A-activated lymphocytes of rats. J Neuroimmunol (2007) 0.79
Non-neural tyrosine hydroxylase, via modulation of endocrine pancreatic precursors, is required for normal development of beta cells in the mouse pancreas. Diabetologia (2014) 0.78
Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice. Cell Tissue Res (2002) 0.77
In vitro immunoblockade of VIP inhibits the proliferation of pituitary prolactin cells. Anat Embryol (Berl) (2005) 0.77
RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist. J Pharmacol Exp Ther (1983) 0.76
Metabolic regulation by alpha 1- and alpha 2-adrenoceptors. Life Sci (1991) 0.76
In vitro and in vivo evidence for direct dopaminergic inhibition of VIP-immunoreactive pituitary cells. Neuropeptides (1994) 0.76